Generics - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

226 to 250 of 469 results

Study on generic HIV drugs prompts AHF to demand Gilead cuts ARV prices

16-01-2013

A new study published in the Annals of Internal Medicine that provides a snapshot of a simplified cost/benefit…

Anti-viralsAtriplaGenericsGilead SciencesNorth AmericaPharmaceuticalPricingStribild

Daiichi Sankyo and Ranbaxy combine business operations in Thailand

16-01-2013

Japanese pharma major Daiichi Sankyo (TYO: 4568) and its 64%-owned affiliate Ranbaxy Laboratories (AB:…

Asia-PacificDaiichi SankyoGenericsManagementMarkets & MarketingPharmaceuticalRanbaxy Laboratories

Indian govt plans compulsory licences for trastuzumab, ixabepilone and dasatinib

15-01-2013

The Indian government's move to issue compulsory licences to three more patented cancer drugs has left…

Asia-PacificAvastinBristol-Myers SquibbGenericsIxempraOncologyPatentsPharmaceuticalRocheSprycel

China now one of the world's largest heparin API producers and exporters; report

13-01-2013

China, abundant in heparin raw materials, has become one of the world's largest heparin API producers…

Asia-PacificCardio-vascularGenericsheparinMarkets & MarketingPharmaceuticalProduction

Australia's pharma sector a net importer but also one of its largest high-tech exporters

13-01-2013

The pharmaceutical product manufacturing industry in Australia is dominated by major global pharmaceutical…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProduction

Hikma to buy Egyptian pharma company for around $20 million

10-01-2013

Fast-growing Jordan-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says it has agreed to acquire…

Egyptian Company for Pharmaceuticals & ChemicGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceuticalRest of the World

US physician acquiescence to patient demands for brand-name drugs, slammed in JAMA article

09-01-2013

Prescribing brand-name drugs when generic drugs are available generates unnecessary medical expenditures…

FinancialGenericsHealthcareNorth AmericaPharmaceuticalPricing

2012 again a bumper year for Pharma M&A, but values well down

09-01-2013

The year 2012 was again a bumper year for merger and acquisition activity in the global pharmaceutical,…

BiotechBiotechnologyGenericsMergers & AcquisitionsPharmaceutical

Pharmaceutical M&A deals in 2012

07-01-2013

Details for the 131 M&A announcements in 2012 recorded by The Pharma Letter are provided in the full…

BiotechGenericsMergers & AcquisitionsPharmaceutical

Questcor Pharmaceuticals to acquire BioVectra for around $50 million

04-01-2013

California, USA-based Questcor Pharmaceuticals (Nasdaq: QCOR) has signed a definitive agreement to acquire…

BiotechnologyBioVectraGenericsMergers & AcquisitionsPharmaceuticalProductionQuestor Pharmaceuticals

Japan Pharma: Expectations for 2013, by P Reed Maurer

03-01-2013

The biggest non-event in the Japan health care market during 2013 will be no reimbursement price reductions,…

Asia-PacificGenericsLicensingMergers & AcquisitionsPharmaceuticalPricingResearch

Canada's Pharmascience sets up JV with Korea Kolmar; buys Rivex

03-01-2013

Privately-held Canadian drugmaker Pharmascience and Korea Kolmar Holdings, based in Seoul, South Korea,…

Asia-PacificBiotechnologyGenericsHelix BioPharmaKorea KolmarMergers & AcquisitionsNeurologicalNorth AmericaPharmaceuticalPharmascienceRivex Pharma

American Capital commits $212 million to acquire Cambridge Major Laboratories

03-01-2013

Private equity firm American Capital (Nasdaq: ACAS) says that it has committed $212 million in the buyout…

American CapitalBiotechnologyCambridge Major LaboratoriesGenericsMergers & AcquisitionsPharmaceutical

JHP Pharmaceuticals acquired by Warburg Pincus for $195 million

02-01-2013

US specialty drugmaker JHP Pharmaceuticals, which acquires, develops, manufactures and sells sterile…

GenericsJHP PharmaceuticalsMergers & AcquisitionsPharmaceuticalWarburg Pincus

Perrigo buys full control of Cobrek Pharma for about $45 million

31-12-2012

US drugmaker Perrigo (Nasdaq: PRGO; TASE) announced on Friday that it has signed a definitive merger…

Cobrek PharmaceuticalsGenericsMergers & AcquisitionsPerrigoPharmaceutical

More transparency on medicine pricing called for by EU parliamentarians

19-12-2012

More transparency and precise time limits for decision-making on pricing and reimbursement of medicines…

EuropeGenericsPharmaceuticalPricingRegulation

Sales of antiretroviral agents for HIV will decline slightly over next decade

18-12-2012

Major-market sales of antiretroviral (ARV) agents for HIV will decline slightly over the next decade,…

Anti-viralsBiotechnologydolutegravirGenericsGlaxoSmithKlineGlobalMarkets & MarketingPharmaceuticalRegulationViiV Healthcare

EMA 2013 work program and budget endorsed by management board

18-12-2012

The European Medicines Agency's Management Board revealed yesterday that, at its meeting on December…

BiotechnologyEuropeFinancialGenericsPharmaceuticalRegulation

No "Japan pharma for sale signs," by P Reed Maurer

18-12-2012

Want to acquire a Japanese pharmaceutical company? Join the back of a long line of companies with the…

Asia-PacificGenericsMergers & AcquisitionsPharmaceutical

Regenstrief study finds that generic drugs often have incorrect safety labeling

16-12-2012

Despite US Food and Drug Administration regulations requiring generic medicines to carry identical warnings…

GenericsMarkets & MarketingNorth AmericaPharmaceuticalRegulation

226 to 250 of 469 results

Back to top